Cancer
Conditions
Brief summary
To validate the usability and safety of the Liberty Analyser.
Interventions
DEVICEEntia Liberty
Home monitoring
Sponsors
Entia Ltd
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Undergoing systemic anti-cancer therapy (SACT) * Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment * Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser * Patients capable of providing written informed consent
Exclusion criteria
* History or current diagnosis of haematological malignancy * Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training * Inadequate use and understanding of the English language, requiring a translator
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The Entia Liberty Analyser is easy to use | Through study completion, 1 day | Users can easily carry out a test using the Entia Liberty Analyser |
| The Entia Liberty Analyser is safe to use | Through study completion, 1 day | Results obtained using the Entia Liberty Analyser are valid and reliable |
Outcome results
None listed